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Abstract
Streptococcus pyogenes is a human commensal and a bacterial pathogen responsible for
a wide variety of human diseases differing in symptoms, severity, and tissue tropism. The
completed genome sequences of >37 strains of S. pyogenes, representing diverse dis-
ease-causing serotypes, have been published. The greatest genetic variation among these
strains is attributed to numerous integrated prophage and prophage-like elements, encod-
ing several virulence factors. A comparison of isogenic strains, differing in prophage con-
tent, would reveal the effects of these elements on streptococcal pathogenesis. However,
curing strains of prophage is often difficult and sometimes unattainable. We have applied a
novel counter-selection approach to identify rare S. pyogenesmutants spontaneously
cured of select prophage. To accomplish this, we first inserted a two-gene cassette contain-
ing a gene for kanamycin resistance (KanR) and the rpsL wild-type gene, responsible for
dominant streptomycin sensitivity (SmS), into a targeted prophage on the chromosome of a
streptomycin resistant (SmR) mutant of S. pyogenes strain SF370. We then applied antibi-
otic counter-selection for the re-establishment of the KanS/SmR phenotype to select for iso-
lates cured of targeted prophage. This methodology allowed for the precise selection of
spontaneous phage loss and restoration of the natural phage attB attachment sites for all
four prophage-like elements in this S. pyogenes chromosome. Overall, 15 mutants were
constructed that encompassed every permutation of phage knockout as well as a mutant
strain, named CEM1ΔΦ, completely cured of all bacteriophage elements (a ~10% loss of
the genome); the only reported S. pyogenes strain free of prophage-like elements. We com-
pared CEM1ΔΦ to the WT strain by analyzing differences in secreted DNase activity, as
well as lytic and lysogenic potential. These mutant strains should allow for the direct exami-
nation of bacteriophage relationships within S. pyogenes and further elucidate how the
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presence of prophage may affect overall streptococcal survival, pathogenicity, and
evolution.
Introduction
Streptococcus pyogenes (Group A streptococci) is a Gram-positive bacterial pathogen capable of
causing a broad spectrum of disease at different sites in the human body. These range from
mild infections like pharyngitis and impetigo to more severe invasive infections such as strep-
tococcal toxic shock syndrome and necrotizing fasciitis (reviewed in Cunningham (1)). When
inadequately treated, these infections can also lead to the development of post-streptococcal
sequelae, such as glomerulonephritis and rheumatic fever [1].
With the advent of more advanced DNA sequencing capabilities and genomic analysis
tools, it is now possible to assess the contribution of a particular genotype to the type and sever-
ity of a streptococcal infection. In 2001, Ferretti et al. reported the first complete genome
sequence of an M1 serotype; strain SF370, isolated from a wound infection [2]. The completed
genome revealed that this streptococcal strain is poly-lysogenized, and that the integrated bac-
teriophages (prophages) encode a number of putative virulence factors, suggesting an intimate
relationship between prophage and streptococcal pathogenesis [2].
The SF370 genome contains many potential mobile genetic elements (MGEs), such as mul-
tiple transposons, one integrative and conjugative element (ICE), and four main bacterio-
phage-like elements (F370.1, F370.2, F370.3 and F370.4/SpyCIM1, summarized in Fig 1).
Only one prophage (F370.1) was previously demonstrated to be inducible into phage particles
by mitomycin C treatment, whereas the other three phage-elements are thought to be defective
in this capacity, but still encode functional genes [2–4]. Phage F370.1 encodes a 41kilobase
(kb) genome and contains the speC superantigen gene and the spd1 DNase gene. Phage F370.2
is encoded by a 43 kb genome and includes two putative superantigen genes (speH and speI).
Phage F370.3, is encoded by a 33 kb genome and harbors another DNase gene (spd3).
The 13 kb genome ofF370.4 contains lysogeny and regulatory modules similar to lambdoid
prophages, but lacks identifiable structural, lysis, or virulence genes [2, 3], and has recently been
renamed SpyCIM1 (Streptococcus pyogenes Chromosomal Island (SpyCI) M1) [5]. We will use
this nomenclature throughout the work presented here, because of its similarity to the phage-
related chromosomal islands identified in Staphylococcus aureus and other Gram-positive bacte-
ria [6–8]. SpyCIM1mediates expression of the methyl-directed mismatch repair (MMR) operon
through a process of dynamic excision and re-integration from the 5’ end of themutL ORF, and
as such has been linked to an increased mutation rate in host bacteria [5, 9].
As of July 2015, the completed chromosomal sequences of approximately 37 other S. pyo-
genes genomes have been published and/or deposited into DDBJ, EMBL, and GenBank, and
represent diverse M-protein (M) serotypes (e.g., M1, M2, M3, M4, M5, M6, M12, M14 M18,
M23, M28, M49, M53, and M59) [2, 10–27]. Although the isolates represent over 13 different
M-serotypes recovered from a variety of different streptococcal diseases, body sites, temporal
and geographical distributions, the core chromosomal coding sequences of the majority of iso-
lates are 90% similar [28]. The highest degree of genetic variation among strains is due to the
numerous phage and phage-like (SpyCI) elements integrated into each of the S. pyogenes chro-
mosomes [2, 14, 15, 20, 28]. All sequenced S. pyogenes genomes are poly-lysogenized, contain-
ing between one to seven bacteriophage or SpyCI elements. Encoded on these prophage are
multiple virulence factors: including superantigens (e.g., SpeH, SpeK, and SpeM),
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streptodornases or DNases (e.g., Spd1/MF2, Spd4, Sda, and Sdn), phage-encoded, antibiotic
resistant cassettes (MefA) [29–31], and phospholipases (Sla) (summarized in [13, 22, 32]).
While comparisons of the published completed genomes show that prophages and pro-
phage-like elements account for most of the sequence differences among various serotypes, in-
depth comparative genomic and microarray analyses have confirmed that phage also account
for the greatest intra-serotype genetic differences [20, 24, 33, 34]. To that point, a retrospective
analysis of the bacteriophage content of different strains within M3-serotypes isolated from
multiple geographical areas between 1920 and 2002 suggests that the successive gain of pro-
phages over time has led to a contemporary M3 strain with increased virulence [14]. Addition-
ally, multiple research groups have provided strong evidence to demonstrate that the rise of the
hyper-virulent M1T1 clone in the late 1980s can be attributed, at least in part, to the horizontal
Fig 1. Location of the major bacteriophage elements in the chromosome of SF370. Triangles represent the location of the four main bacteriophage-like
elements in the circular genome of S. pyogenes strain SF370. Numbers in triangles represent the corresponding phage elements with their size and encoded
virulence factors identified in the table below. Derived from GenBank nucleotide accession number: AE004092.
doi:10.1371/journal.pone.0146408.g001
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acquisition of a 36-kb chromosomal segment (from a serotype M12 strain) and two separate
bacteriophages, encoding different virulence determinants: a highly-active secreted DNase
(Sda1/SdaD2) and the superantigen (SpeA) [10, 33–37].
These analyses highlight the importance of bacteriophages in streptococcal diversity, and
provide preliminary evidence for a mechanism by which certain “virulent clones” could quickly
evolve through horizontal transfer of prophage-like elements. Additionally, phage can play a
more general role in evolution as a mechanism of horizontal gene transfer, through generalized
transduction and recombination within the streptococcal chromosome [15, 36, 38, 39].
A comparison of isogenic strains of S. pyogenes that differ in specific bacteriophage genes or
in overall bacteriophage content would allow us to study the direct effects that individual bacte-
riophage have on streptococcal virulence and may provide insight into the evolution of patho-
genicity of specific strains in relation to prophage integration or loss.
In this study, we describe a genetic methodology that specifically manipulates the presence
of integrated Group A streptococcal bacteriophage and SpyCIM1 elements, to produce isogenic
mutants that are consecutively cured of prophages and differ only in prophage and prophage-
like content. In total, we constructed 15 different knockout (KO) mutants of the M1 strain
SF370, which represent every possible combination of phage and SpyCIM1 deletions, and addi-
tionally created the first mutant S. pyogenes strain (CEM1ΔF) that is completely cured of all
major bacteriophage-like elements (a loss of ~10% of the original genome). We then compared
the full phage KO (CEM1ΔF) to the wild type (SF370SmR) to examine a subset of contribu-
tions that could be attributed to prophage presence in the S. pyogenes genome, such as mor-
phology, in vitro growth rate, secretion of phage encoded virulence factors, and lytic and
lysogenic bacteriophage interactions.
Materials and Methods
Bacterial Strains and Growth Conditions
S. pyogenes strain SF370 (an M1 serotype) was isolated from a wound infection and kindly
provided by J. Ferretti, University of Oklahoma Health Sciences Center [2]. A spontaneous
streptomycin-resistant derivative of SF370 (discussed below) will be referred to as SF370SmR
throughout these studies. All of the isogenic phage deleted mutants were derived from this
S. pyogenes background (Table 1). One Shot1 TOP10 E. coli (strain DH5α) (Invitrogen /
ThermoFisher Scientific, Grand Island, NY) was used for plasmid construction and vector
propagation.
E. coli was cultured in Luria-Bertani (LB) broth and on LB agar at 37°C. S. pyogenes strains
were grown at 37°C without shaking in Brain Heart Infusion (BHI) broth or Todd Hewitt
Broth plus 2% yeast extract (THY) medium and on Proteose Peptone No.3 supplemented with
4% defibrinated sheep blood (Cleveland Scientific, Bath, OH) (PPB) agar or Columbia Blood
Agar plates. When required, media was supplemented with antibiotics at the following concen-
trations: erythromycin at 200 μg/ml for E. coli and 15 μg/ml for S. pyogenes; kanamycin at
50 μg/ml for E. coli and 250 μg/ml for S. pyogenes; streptomycin at 200 μg/ml for S. pyogenes.
All antibiotics were supplied by Sigma-Aldrich (St. Louis, MO). All media was supplied by
Difco (BD, Becton, Dickinson and Company, Hunt Valley, MD) unless stated otherwise.
DNAManipulations
Streptococcal genomic DNA was isolated with either the DNeasy Tissue Kit or the Blood &
Cell Culture DNA Kit (Qiagen, Germantown, MD) following the manufacturer’s protocols,
except for the substitution of a modified lysis buffer (50 mM Tris-Cl pH 6.6, 50 mM EDTA,
0.5% Tween-20, 0.5% TritonX-100) supplemented with 500U of PlyC, a streptococcal
Curing Bacteriophage from Streptococcus pyogenes
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Table 1. Strains described in this study.
Straina Bacteriophage and/or gene deletedb Antibiotic resistance phenotypeb Refererence or source
Streptococcus pyogenes
SF370 WT—None KanS SmS [7]
SF370SmR WT—None KanS SmR This study
WT + counter-selection cassette
CEM1KRΔspeC speC (Φ370.1 superantigen ORF) KanR SmS This study
CEM1KRΔspeH speH (Φ370.2 superantigen ORF) KanR SmS This study
CEM1KRΔspd3 spd3 (Φ370.1 DNase ORF) KanR SmS This study
CEM1KRΔspy2136 spy2136 (SpyCIM1 primase ORF) KanR SmS This study
Single phage KOs
CEM1Δ1 Φ370.1 KanS SmR This study
CEM1Δ2 Φ370.2 KanS SmR This study
CEM1Δ3 Φ370.3 KanS SmR This study
CEM1Δ4 SpyCIM1 KanS SmR This study
Single phage KOs + counter-selection cassette
CEM1KRΔ2-speC Φ370.2, speC KanR SmS This study
CEM1KRΔ1-spd3 Φ370.1, spd3 KanR SmS This study
CEM1KRΔ1-spy2136 Φ370.1, spy2136 KanR SmS This study
CEM1KRΔ2-spd3 Φ370.2, spd3 KanR SmS This study
CEM1KRΔ2-spy2136 Φ370.2, spy2136 KanR SmS This study
CEM1KRΔ4-spd3 SpyCIM1, spd3 KanR SmS This study
Double phage KOs
CEM1Δ1,2 Φ370.1, Φ370.2 KanS SmR This study
CEM1Δ1,3 Φ370.1, Φ370.3 KanS SmR This study
CEM1Δ1,4 Φ370.1, SpyCIM1 KanS SmR This study
CEM1Δ2,3 Φ370.2, Φ370.3 KanS SmR This study
CEM1Δ2,4 Φ370.2, SpyCIM1 KanS SmR This study
CEM1Δ3,4 Φ370.3, SpyCIM1 KanS SmR This study
Double phage KOs + counter-selection cassette
CEM1KRΔ1,2-spd3 Φ370.1, Φ370.2, spd3 KanR SmS This study
CEM1KRΔ1,2-spy2136 Φ370.1, Φ370.2, spy2136 KanR SmS This study
CEM1KRΔ1,4-spd3 Φ370.1, SpyCIM1, spd3 KanR SmS This study
CEM1KRΔ2,3-spd3 Φ370.2, SpyCIM1, spd3 KanR SmS This study
Triple phage KOs
CEM1Δ1,2,3 Φ370.1, Φ370.2, Φ370.3 KanS SmR This study
CEM1Δ1,2,4 Φ370.1, Φ370.2, SpyCIM1 KanS SmR This study
CEM1Δ1,3,4 Φ370.1, Φ370.3, SpyCIM1 KanS SmR This study
CEM1Δ2,3,4 Φ370.2, Φ370.3, SpyCIM1 KanS SmR This study
Triple phage KOs + counter-selection cassette
CEM1KRΔ1,2,4-spd3 Φ370.1, Φ370.2, SpyCIM1, spd3 KanR SmS This study
Quadruple phage KO
CEM1ΔΦ Φ370.1, Φ370.2, Φ370.3, SpyCIM1 KanS SmR This study
Re-Lysogenized strains
CEM1Δ1−C1 Φ370.1 (+ Φ370.1) KanS SmR This study
CEM1ΔΦ−C1 Φ370.1, Φ370.2, Φ370.3, SpyCIM1, (+ Φ370.1) KanS SmR This study
Escherichia coli
(Continued)
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bacteriophage lysin [40] and 250 ng/ml of RNase A (Qiagen). Plasmid DNA was isolated from
E.coli using the QIAprep Spin Miniprep Kit or HiSpeed Plasmid Midi Kit (Qiagen). DNA frag-
ments were gel purified from 1% Agarose gels using the QIAquick Gel Extraction Kit (Qiagen).
T4 DNA ligase and all restriction enzymes, unless otherwise stated, were purchased from New
England Biolabs (Ipswich, MA) and used according to the manufacturer’s instructions unless
otherwise stated. Oligonucleotide primers were obtained from Fisher Scientific-Operon (Pitts-
burgh, PA) and are listed in (S1 Table). PCR was performed using AmpliTaq Gold DNA poly-
merase, Gold Buffer, 1.5 mMMgCl2, and 200 μM dNTPS (Applied Biosystems, Foster City
CA) following standard protocols with the Eppendorf Mastercycler (Eppendorf, Hauppauge,
NY). Southern blot analysis utilized probes from the primers & PCR products described in (S1
Table) with the Amersham ECL Direct Nucleic Acid Labeling and Detection System (GE
Healthcare Biosciences, Pittsburgh, PA). DNA sequencing was performed by GENEWIZ, Inc.
(North Brunswick, NJ). DNA sequence analysis, comparison, and manipulation were accom-
plished with Lasergene software modules (DNASTAR Inc., Madison, WI). DNA primers were
designed with MacVector software (Accelrys Inc., San Diego, CA).
Isolation of SF370 with a Genomic Mutation Conferring Streptomycin
Resistance
A spontaneous streptomycin-resistant mutant of strain SF370 was selected by serial passage in
BHI containing increasing concentrations of the antibiotic (0–200 μg/ml), followed by growth
on PPB agar containing 200 μg/ml streptomycin. In order to confirm that a mutation in the
rpsL gene caused the SmR phenotype, the gene was PCR amplified and the DNA sequence com-
pared to published rpsL sequences from the SF370 genome and other types of SmR bacteria,
[41–44]. The resulting SmR strain was used in all subsequent bacteriophage deletion experi-
ments and is referred to as SF370SmR.
Construction of Bacteriophage Counter-Selection Vector, pFWKR
To generate the counter-selection vector, the 676 bp DNA sequence of the SF370 rpsLWT gene
and upstream promoter region, was inserted between the kanamycin resistance gene (aacA-
aphD) and a downstream multiple cloning site (MCSII) of the streptococcal shuttle vector
pFW13 [45], as described in the (S1 Fig). The recombinant vector was transformed into E. coli
and transformants selected on LB agar containing kanamycin. Plasmid DNA was isolated from
the KanR cultures and sequenced to verify proper insertion of the WT rpsL gene into the vector.
The resulting two-gene ((aacA-aphD) / rpsLWT) positive/negative selection cassette was desig-
nated as a “Janus cassette” based on a similar counter-selection cassette used for gene replace-
ment in Streptococcus pneumoniae [46]. The plasmid, which contained our Janus cassette, was
named pFWKR and served as the backbone to construct all other phage counter-selection vec-
tors (S1 Fig).
Table 1. (Continued)
Straina Bacteriophage and/or gene deletedb Antibiotic resistance phenotypeb Refererence or source
One Shot DH5α Used for cloning and propagation of the counter-selection vectors Invitrogen
a Phage number or gene to the right of the Δ symbol have been deleted; KR, contains counter-selection cassette ((aacA-aphD) / rpsLWT).
b Abbreviations used: WT, wildtype; ORF, open reading frame; (+ Φ370.1), gain of Φ370.1; KanR, kanamycin-resistant; KanS, kanamycin-sensitive; SmR,
streptomycin-resistant; SmS, streptomycin-sensitive.
doi:10.1371/journal.pone.0146408.t001
Curing Bacteriophage from Streptococcus pyogenes
PLOSONE | DOI:10.1371/journal.pone.0146408 January 12, 2016 6 / 22
Counter-Selection Step 1: Allelic Replacement of a Bacteriophage ORF
with the pFWKR Janus Cassette
The speH superantigen gene encoded by phage F370.2 was chosen first for allelic replacement
since we previously showed it could be successfully replaced with other antibiotic resistance
genes [47]. Following the allelic replacement protocols described above and published previ-
ously [47] the speH gene was replaced with the Janus cassette contained in the pFWKR vector
above. To accomplish this, the DNA regions flanking speH were separately PCR amplified
from SF370 (662 bp upstream and 888 bp downstream) using the two primer sets described by
Ryan et al. (S1 Table) [47]. The amplicons and pFWKR vector were digested with the corre-
sponding restriction enzymes, gel purified, and the individual upstream and downstream frag-
ments were cloned into the MCSI and MCSII, respectively. The resulting plasmid DNA was
PCR amplified and sequenced to confirm the creation of this pFWKR-speH vector (S1 Table).
The pFWKR-speH vector was then electroporated into strain SF370 following the protocol of
Kimoto and Taketo [48], and transformants were selected on PPB containing kanamycin.
KanR colonies were then plated on PPB agar containing kanamycin (250 μg/ml) and strepto-
mycin (200 μg/ml) to verify SmS, conferred by the WT rpsL gene in the replacement cassette.
Double mutants (KanR/SmS) were screened by PCR and Southern blot analyses to verify the
proper allelic replacement of the speH gene with the Janus cassette (data not shown). The
resulting mutant, CEM1KRΔspeH, was then used to screen for the loss of the entire F370.2
bacteriophage (Table 1).
Counter-Selection Step 2: Selection of Mutants Cured of Bacteriophage
To cure the CEM1KRΔspeH mutant of the F370.2 phage, a single colony was inoculated into
BHI broth, without antibiotics, and grown overnight at 37°C. The overnight culture was plated
onto PPB agar containing streptomycin (200 μg/ml), and once again incubated overnight at
37°C to select for SmR colonies that potentially lost the phage harboring the Janus cassette. To
confirm cassette loss and eliminate false positive SmR colonies, caused by point mutations or
gene conversion events in the rpsLWT gene, SmR colonies were replica plated to PPB agar con-
taining kanamycin to identify isolates that were also KanS. The (SmR / KanS) mutants were
then verified for complete loss of the F370.2 phage by PCR (using primer sets spanning both
sides of the bacteriophage integration or attachment sites) (S1 Table), Southern blot hybridiza-
tion analysis (with F370.2 specific gene probes), DNA sequence analysis, and PFGE analysis.
The resulting mutant strain, CEM1Δ2, no longer contained the integrated F370.2 DNA in the
streptococcal chromosome (Table 1).
Selection for the Loss of the Three Additional Bacteriophage-Like
Elements from SF370
Unless otherwise stated in the results, the two-step method to cure SF370SmR of the three
remaining prophage was accomplished using the same techniques described above for the dele-
tion of the F370.2 bacteriophage, except that the counter-selection pFWKR-like plasmids for
each remaining prophage element were constructed using a combination of PCR based fusion
assembly and cloning methods adapted from S. Lizano et al. [49, 50]. Briefly, instead of restric-
tion digestion and individual ligation into the MCSs of pFWKR, the corresponding amplicons
of the upstream and downstream DNA regions (500 bp– 1400 bp) adjacent to each of the viru-
lence genes from the individual prophage were fused to both sides of a third PCR amplicon
that contained the Janus cassette from plasmid pFWKR. Full-length products were then ampli-
fied by another round of PCR with nested primers that had homology to the far ends of the
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adjacent upstream and downstream regions and contained a NheI or XmaI site. The fused
amplicons, containing the Janus cassette flanked by phage DNA, and the pFWKR plasmid
were then double-digested with the corresponding enzymes and ligated together to derive the
counter-selection plasmids similar in composition to the pFWKR-speH vector above (Plasmids
and Primers summarized in S1 Table). The resulting vectors were used for transformation and
allelic replacement in SF370SmR, CEM1Δ2, and each subsequent bacteriophage deletion
mutant. In each case, our Janus cassette was individually inserted into the remaining prophage,
replacing virulence genes, (speC, F370.1; spd3, F370.3,) or the replicase gene (spy2136) of Spy-
CIM1. After growth and antibiotic counter-selection, proper phage loss in the SmR/KanS colo-
nies was confirmed by the above analyses (S1 Table and S2 Fig). For the derivation of the
multiple phage deletion mutants, the experimental progression of phage counter-selection and
consecutive phage loss always followed the order of: F370.2, F370.1, SpyCIM1, and then
F370.3 (first to last respectively). This process was repeated until every permutation of phage
loss was obtained (15 mutants in all), including a strain that was devoid of all major bacterio-
phage-like DNA sequences named CEM1ΔF (summarized in Table 1).
PFGEMolecular Analysis
Agarose discs of genomic DNA from SF370SmR and mutant isolates (Table 1) were prepared
according to a protocol modified from Chung et al. [51], in which 500U of PlyC was substi-
tuted for lysozyme and lysostaphin enzymes in the cell lysis solution [40]. DNA was digested
with SmaI overnight at 25°C and subjected to PFGE with the CHEF-DR II system (Bio-Rad,
Hercules CA) as previously described [51, 52]. DNA bands in the agarose gel were visualized
with ethidium bromide and photographed with an Alpha imager (Alpha Innotech Corp., San
Leandro, CA). DNA banding patterns were analyzed by previously described methods [51, 53].
Comparison of DNase Activity in Bacteriophage Cured Strains
Overnight cultures of SF370SmR and CEM1ΔF grown in BHI or individual colonies grown on
Columbia Blood Agar plates were streaked for isolation onto DNase Test Agar with Methyl
Green (Difco). After overnight incubation at 37°C, the size of clearing zones surrounding colo-
nies, which indicated DNase activity on the DNA-methyl green substrate in the agar, were
compared for a qualitative assessment of DNase activity of each strain.
Mitomycin C Induction of Prophage
Prophage were induced using a modification of the method of McShan et al. [54]. Briefly, WT
SF370 (SmS), CEM1ΔF, and other phage cured mutants were grown overnight at 37°C in BHI
broth. The overnight culture was diluted 1:30 (v/v) in 100 ml of BHI broth and incubated at
37°C to an O.D.600 of 0.2. The culture was then divided, one half received mitomycin C
(Sigma) at 0.2 μg/ml and the other half served as a control. After two hours at 37°C the optical
density of the mitomycin C induced culture of SF370 began to drop. This decrease was not
observed in either the untreated controls or the mitomycin C treated CEM1ΔF cultures (data
not shown). Cells were then pelleted by centrifugation and supernatants collected and sterile-
filtered through 0.22 μm filters. Filtrates were concentrated and buffer exchanged with 100,000
MWCO Amicon Ultra-15 centrifugal filter devices (Millipore) to achieve a final volume of
500 μl in prophage suspension buffer [55] (0.15 M NaCl, 10 mM Tris HCl [pH 7.5], 5 mM
MgCl2, 1 mM CaCl2) These concentrated phage stocks were stored at 4°C for a maximum of
72 hours before being used.
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Analysis of Bacteriophage Plaques and Lysogens
Potential indicator strains, (SF370SmR, CEM1ΔF, and the single phage KO mutants in
Table 1) were grown overnight at 37°C in BHI broth containing 200 μg/ml of streptomycin.
Aliquots (100 ul) of these cultures were added to 3 ml of melted BHI soft agar (7.5%) at 50°C,
mixed, and poured on top of PPB agar plates. After the agar solidified, 10 μl of the concentrated
phage stocks were spotted onto the plates. Phage supernatants spotted to PPB agar plates alone
(without indicator strain) served as control for bacterial contamination. Plates were incubated
overnight (37°C plus 5% CO2) and analyzed for growth inhibition and bacteriophage plaques
The same extent of growth inhibition or killing was not observed in concentrated control
media containing only mitomycin C.
To screen for lysogens, colonies around the edge of the plaque clearing zones, or non-plaque
areas where lysates were dropped on lawns, were picked and streaked for isolation on PPB agar
plates containing streptomycin (200 μg), to inhibit WT SF370 (SmS) bacterial contamination.
Streptomycin resistant colonies were then analyzed for lysogeny by PCR amplification, using
primers specific to bacteriophage genes from each of the four major elements of SF370 (S1
Table). Colonies that had positive amplicons were further analyzed for proper phage integra-
tion using PCR primers specific for the SF370 phage attachment sites (S1 Table). The genomic
DNA from putative lysogens was then subjected to PFGE analysis to ensure there were no
other non-specific integration events or gross chromosomal arrangements.
Results
Principle of Prophage Counter-Selection Technique
To isolate mutants cured of prophage, we used allelic replacement techniques to exchange indi-
vidual prophage genes with a two-gene Janus cassette containing: 1) the (aacA-aphD) gene,
encoding kanamycin resistance (KanR) [45] and 2) the wild-type rpsL gene (rpsLWT), encoding
the ribosomal subunit protein S12, the target of the antibiotic streptomycin [46, 56]. While
point mutations in the chromosomal rpsL gene provide a high level of resistance to streptomy-
cin (SmR), the resistance is recessive if a second copy of the gene (rpsLWT) is also expressed in
the same cell [56, 57]. Therefore, if the rpsLWT gene is introduced by allelic replacement into a
prophage of a strain harboring a chromosomal rpsLmutation (naturally SmR), the strain will
become streptomycin sensitive (SmS). Such a system makes it possible to select for rare clones
that spontaneously lose the prophage-inserted copy of the rpsLWT allele and to counter-select
against genetic elements that harbor a copy of rpsLWT by plating the bacteria on media contain-
ing streptomycin [56]. Isolates that retain the rpsLWT copy (i.e. the prophage) will be SmS,
while strains that are spontaneously cured of the prophage carrying the rpsLWT gene will be
SmR.
Selection for the Loss of Bacteriophage and SpyCIM1
We first isolated a mutant strain of SF370 that had become spontaneously resistant to strepto-
mycin as described in the Methods section. DNA sequence analysis of the rpsL region of this
mutant revealed a single point mutation in the rpsL gene (lysine 56 to arginine (K56R)), which
is consistent with rpsLmutations that confer streptomycin resistance in other bacterial species
[42–44, 46]. No gross differences were observed in growth rate or morphology between the
streptomycin resistant mutant (SF370SmR) andWT strain of SF370 (data not shown).
Next, SF370SmR was transformed with the counter-selection vector, pFWKR-speH (S1
Table), to replace the speH gene in F370.2 with the Janus cassette and create the KanR/SmS
mutant CEM1KRΔspeH (Table 1). This mutant was grown overnight in media without
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antibiotics and plated on streptomycin agar plates to select for an isolate that spontaneously
lost the F370.2 prophage, containing the Janus cassette, thus reverting back to the KanS/SmR
phenotype of SF370SmR. Complete loss of the F370.2 phage DNA and absence of gross chro-
mosomal alterations were confirmed for this mutant (and all subsequent mutants) by four dif-
ferent methods: 1) lack of PCR amplification products specific for F370.2 genes (S1 Table), 2)
Southern blot analysis with F370.2 phage specific probes described in S1 Table (data not
shown), 3) PFGE analysis (Fig 2), and 4) sequencing across the attB phage integration site.
The resulting mutant strain, CEM1Δ2 (Table 1), lacked the integrated F370.2 DNA and
recapitulated the predicted attB bacterial attachment site from the SF370WT genome sequence
(Table 2). Furthermore, the nucleotide sequence of this region was identical to that of a modern
M1 strain, MGAS5005, which does not contain a bacteriophage integrated into the homolo-
gous genome location [2, 10].
To select for loss of the F370.1 phage, the speC gene was replaced with the Janus cassette to
create the mutant CEM1ΔspeC. This strain was then passaged and subjected to our counter
selection methods to isolate colonies that had a potential phage deletion. Genomic DNA from
these clones was screened by the four confirmatory methods listed above to verify that F370.1
was lost and that there were no aberrant recombination events in the production of the mutant
named CEM1Δ1 (Fig 2 and Tables 1 and 2). Using this same procedure, CEM1Δ2 was also
cured of F370.1 to produce the double phage (F370.1 and F370.2) deletion mutant
CEM1Δ1,2. (Table 1 and S2 Fig).
To select for loss of SpyCIM1 we replaced the phage primase gene (spy2136), with the Janus
cassette to create the CEM1KRΔSpy2136 mutant (Table 1). We hypothesized that deletion of
the primase gene might interfere with replication of the excised circular form of SpyCIM1,
potentially promoting loss of the element during cell division. However, all resulting mutants
(> 500 CFU) were SmR/ KanR, suggesting a rate of recombination, gene conversion or muta-
tion in the rpsLWT gene of the Janus cassette was significantly higher than the rate of loss of
SpyCIM1 [46]. This confirmed previous results that SpyCIM1 was difficult to cure from SF370
[5, 7, 58].
To increase the probability of isolating a mutant cured of SpyCIM1 we adapted a plasmid
curing protocol from [59], in which CEM1KRΔSpy2136 cultures were. incubated in BHI at
42°C for 17 hours, then subsequently plated to streptomycin PP3 agar at 37°C. Resulting SmR/
KanS colonies were confirmed to have lost SpyCIM1 by PCR, Southern blot and PFGE analyses
(data not shown). One such mutant was chosen for further analysis and was designated
CEM1Δ4 (Table 1 and Fig 2). Of note, compared to the wild type background, SpyCIM1 was
lost more efficiently from the other prophage-deleted mutants, CEM1Δ1, CEM1Δ2, and
CEM1Δ1,2 using our standard counter-selection protocol at 37°C. This suggests that the other
prophage may act as helper phages that aid in the maintenance and/or spread of SpyCIM1.
The resulting double and triple phage cured mutants are listed in (Table 1) and PFGE patterns
represented in (S2 Fig).
To isolate a deletion mutant of F370.3 the spd3 gene was replaced with the Janus cassette to
create the CEM1KRΔspd3mutant, followed by counter selection to obtain strain CEM1Δ3
(Table 1), cured of F370.3 (Fig 2 and Table 2). This phage was also deleted from the preceding
single and double mutants using the same vector and methods (Table 1). Finally, the triple KO
mutant (CEM1Δ1,2,4), was similarly manipulated to select for the loss of F370.3 and derive
the first Group A streptococcal strain devoid of all phage and phage-like elements, named
CEM1ΔF (Table 1, Fig 2 and S2 Fig).
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Phenotypic Comparison and Decreased Production of DNase in
Bacteriophage-Free Mutant CEM1ΔΦ
In our first set of analyses, we examined the basic phenotypes of CEM1ΔF as compared to the
SF370SmR wild type strain. We found no significant differences in microscopic appearance of
cells including morphology or streptococcal chain length, or in macroscopic characteristics
such as colony morphology or hemolytic patterns on sheep blood agar. Furthermore, the
Fig 2. Pulse field gel electrophoresis (PFGE) analysis of S. pyogenes SF370SmR and single phage deletionmutants. PFGE patterns of SmaI
digested genomic DNA from A, the phage wild type (WT) strain SF370SmR and the single phage KOs CEM1Δ(1–4), and B, the quadruple full phage KO
CEM1ΔΦ compared to WT strain SF370. Labeled arrows indicate DNA fragments that contain the corresponding integrated phage or phage-like elements,
based on the genome sequence of SF370. A loss or drop of these DNA fragments represents a phage or SpyCIM1 deletion. Numbers at top indicate which
phages have been deleted: 1,Φ370.1 (40.9kb), strain CEM1Δ1; 2,Φ370.2 (42.5 kb), strain CEM1Δ2; 3,Φ370.3 (33.5Kb), strain CEM1Δ3; 4,Φ370.4/
SpyCIM1 (13.5kb), strain CEM1Δ4; (1,2,3,4), all 4 phage elements deleted to create strain CEM1ΔΦ. All lanes in A and B originated from the same PFGE gel
as shown in (S2 Fig). λ, Lambda ladder, New England Biolabs PFGMarker with DNA fragment sizes on adjacent to gel images.
doi:10.1371/journal.pone.0146408.g002
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growth curves produced during liquid culture in enriched laboratory media (THY and BHI)
did not reveal appreciable differences in growth rate (data not shown).
Next, we assessed the production of virulence factors whose expression might be modulated
by the lack of prophage. As one example, we examined the secretion of streptococcal DNases,
which have been shown to affect survival, virulence, and pathogenicity in other S. pyogenes
strains [35, 60]. The genome of SF370 (SF370SmR) encodes three secreted DNases: one that is
chromosomally encoded (spd/mf1) and two others that are phage-encoded (spd1 on F370.1
and spd3 on F370.3) [2, 3, 61]. To assess the production of the phage-encoded DNases as com-
pared to the chromosomal encoded gene alone, strain CEM1ΔF and the wild-type strain
SF370SmR were plated on DNase Test Agar with Methyl Green. After overnight growth, colo-
nies from SF370SmR produced larger and more distinct clearing zones of DNA degradation
than the CEM1ΔF colonies (Fig 3 and S3 Fig). This suggests that the phage DNases contribute
to the total secreted DNase activity of the wild-type strain and/or the presence of prophage
may influence the expression and/or secretion of the chromosomally encoded DNase.
Interactions of CEM1ΔΦ with SF370 Induced Bacteriophage
To test if the CEM1ΔF phage-cured mutant could be re-infected, lysed and/or lysogenized by
induced SF370 WT bacteriophages, concentrated phage supernatants from mitomycin C
induced or non-induced cultures were tested on SF370SmR or CEM1ΔF indicator strains.
When applied to the SF370SmR indicator strain, there was no substantial growth inhibition or
plaque formation observed for any of the six phage supernatants listed in Table 3. Likewise,
none of the supernatants from any non-induced cultures or from the mitomycin C induced
Table 2. Confirmed phage attB sequences in S. pyogenes SF370 prophage KOmutants.
Prophage Prophage-KO attB sequencesa
Φ370.1 CATGTACAACTATACT
Φ370.2 AACTCAAGAAGTGATTAAATAAAACATTAAAGAACCTTGTCATATCAACG
Φ370.3 AATTATTTAACAGCGTCTTT
SpyCIM1 CAATAATGTTTGTCATAATTT
a All sequences are listed 5' to 3' on the forward strand of streptococcal DNA sequences and match predicted attB from SF370, as well as attB from other
published S. pyogenes genomes that lack prophage at these sites. attB, phage attachment sites on bacterial chromosome.
doi:10.1371/journal.pone.0146408.t002
Fig 3. Secreted DNase activity of SF370SmR and CEM1ΔΦ. Both strains were cultured on the same
DNase Test Agar plate with Methyl Green for 17 h. A, SF370SmRWT colonies; B, CEM1ΔΦ full phage KO.
Clearing zones around the colonies resulted from hydrolysis of the DNA-methyl green substrate, and signify
DNase activity.
doi:10.1371/journal.pone.0146408.g003
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CEM1ΔF showed discernable growth inhibition or plaque formation on the CEM1ΔF indica-
tor. However, the supernatant from mitomycin C treated SF370 WT strain did produce signifi-
cant bacterial clearance and/or plaque formation on the lawn of the CEM1ΔF indicator strain
(Table 3).
To assess which SF370 bacteriophage was involved in plaque formation on CEM1ΔF, con-
centrated supernatants from mitomycin C-induced SF370 cultures were dropped onto soft
agar overlays that contained SF370SmR, each of the single phage-deleted mutants (CEM1Δ1,
CEM1Δ2, CEM1Δ3, and CEM1Δ4), or CEM1ΔF. Substantial plaque clearing zones were only
observed on the lawns of the CEM1ΔF and CEM1Δ1 mutants (Table 3). Since plaque forma-
tion is often inhibited by superinfection exclusion [62], these results suggested that the F370.1
phage was responsible for the majority of plaque clearing zones on the lawns of CEM1ΔF. This
interpretation was further supported by the formation of plaques on CEM1ΔF using mitomy-
cin C induced lysate from strain CEM1Δ2,3,4, which only contains the F370.1 phage. No pla-
ques or clearing zones were observed on CEM1ΔF with any of the other triple phage KO
mutants that contained only one of the other prophages-like elements (F370.2, F370.3, or Spy-
CIM1) (Table 3).
To assay for lysogeny, CEM1ΔF or CEM1Δ1 colonies were picked and plated for isolation
from the plaque borders of lawns treated with the Mitomycin C induced phage lysate of SF370.
Additionally, lawn regions of the other single phage KO mutants that were treated with SF370
phage lysate, but were negative for plaque formation were also picked and plated for isolation.
Approximately 100 colonies (SmR) of each recipient indicator strain were screened for inte-
grated phage by PCR analysis with primers specific for each of the four elements. While we did
not detect any F370.2 or F370.3 bacteriophage genes, we identified the F370.1 phage speC
gene in DNA from the colonies of CEM1ΔF and CEM1Δ1. From these isolates, lysogeny and
proper phage integration into the original F370.1 (attB) site were confirmed by PCR, DNA
sequence analysis, and PFGE (data not shown). Two lysogens, which retained the integrated
F370.1 prophage in the chromosome after successive passage, were designated CEM1ΔF-C1
and CEM1Δ1-C1 (Table 1). Additionally, during the course of these studies, further PCR
screens of potential CEM1ΔF lysogens also identified the spy2136 primase gene of SpyCIM1.
These preliminary results indicate that this element might also be transferred and possibly inte-
grate into the genome of the CEM1ΔFmutant (data not shown). In-depth analyses of these
findings are currently underway.
Table 3. Lytic potential of phage KOmutants.
Mitomycin C Induced Φ Lysate Indicator Lawnsa
SF370SmR CEM1ΔΦ CEM1Δ1 CEM1Δ2 CEM1Δ3 CEM1Δ4
SF370 - + + - - -
CEM1ΔΦ - - - - - -
CEM1Δ2,3,4 - + + N/A N/A N/A
CEM1Δ1,2,3 - - - N/A N/A N/A
CEM1Δ1,2,4 - - - N/A N/A N/A
CEM1Δ1,3,4 - - - N/A N/A N/A
a +, positive plaque clearing zones; -, no substantial plaque clearing zones; N/A, not performed
doi:10.1371/journal.pone.0146408.t003
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Discussion
Comparative genomic studies of the published sequences of S. pyogenes isolated from diverse
streptococcal infections have confirmed the important relationship between S. pyogenes and its
lysogenic bacteriophages [20, 24, 33, 34, 55]. While phage are known to play a role in strepto-
coccal pathogenesis because of their encoded virulence factors, the overall molecular and
genetic interactions between phage and the host have not been adequately explored [35, 60,
63–66]. As such, a comparison of isogenic strains of S. pyogenes that differ in specific bacterio-
phage content would allow us to study the direct effects that individual bacteriophage have on
the streptococcal genome and pathogenesis.
Previous methods promoting phage loss in other bacterial species have relied on the use of
DNA-damaging reagents to activate the bacterial SOS response (i.e., mitomycin-C, ethidium
bromide or UV light), which increase both phage induction and the rate of loss of the inte-
grated phage from the genome [67–69]. However, because the nature of these techniques
induces DNA damage, they have the potential to cause mutations in other areas of the bacterial
chromosome, leading to false phenotypes or misleading conclusions regarding the differences
observed between two potential isogenic mutants. These methods also fail to give the
researcher control over which phage are cured from poly-lysogenized bacteria, including S.
pyogenes. While simply passaging and screening large numbers of bacterial colonies for phage
loss by PCR may be useful for other species [70], we, along with others in the Group A strepto-
coccal field, have found such non-selective methods to be unacceptable for isolating S. pyogenes
mutants that differ in lysogeny (unpublished results).
The counter-selection technique presented here allows for precise manipulation of lysogeny
by selecting for spontaneous loss of targeted phage in a way that naturally recapitulates or pre-
serves the attB of each prophage integration site. Additionally, by targeting potential virulence
factors or other phage genes of interest for allelic replacement with the Janus cassette, with rela-
tively little extra effort the investigator can also use the primary KanR/SmS isolates to interro-
gate an individual gene KO, before or after a phenotype is seen in a phage cured strain. Thus,
from the same cloned KO vector and one streptococcal transformation (allelic replacement)
procedure, it is also possible to screen phenotypes associated with the loss of a single phage
gene or the whole bacteriophage genome.
Furthermore, because the loss of phage is concomitant with the loss of the antibiotic selec-
tion cassette (resulting in a marker-less phenotype), this method can be used to consecutively
select for the loss of multiple prophage from the same bacterial chromosome. Previous experi-
ments have taken advantage of this trait by inserting the rpsLWT gene into plasmids for
counter-selection against extra-chromosomal shuttle vectors and single crossover integration
events in S. pyogenes [71]. Likewise, a similar counter-selectable cassette with a rpsLWT gene
and kanamycin resistance marker, originally termed a “Janus Cassette”, has been used to create
silent (marker-less) mutations and gene deletions through gene replacement in Streptococcus
pneumoniae [46]. While other comparable counter-selection or temperature-sensitive genes
and methods have been applied to delete pathogenicity islands and bacteriophages from other
genera of Gram-positive and Gram-negative bacteria [72–74], to our knowledge these types of
methods have not been applied to delete specific prophage in Group A streptococci.
As a proof of concept, we created mutants of the S. pyogenes strain SF370SmR that varied in
phage content as well as a mutant that was devoid of all of the major integrated bacteriophage
elements (a loss of ~10% of the genome). In total we isolated 15 different mutants that comprise
every permutation of the SF370SmR phage knockout (KO): single, double, and triple knockouts,
in addition to the strain that was completely cured of all bacteriophage elements. To our knowl-
edge, this is the first time such mutants of S. pyogenes have been successfully created, and serves
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as a novel method for creating isogenic mutants of S. pyogenes (or potentially other bacteria) that
differ solely in phage content. Such KO strains will be useful tools to study the dynamics of phage
lysogeny, the role phage play in both bacterial virulence and the regulation of chromosomal
genes [58], and can provide insight into the evolution of streptococcal pathogenicity.
In the work presented here, we have demonstrated some preliminary examples of the diverse
applications of these phage-cured mutants for analyzing the role of phage in S. pyogenes pathogen-
esis and to further study the molecular interactions between phage-encoded factors of streptococci.
While it was shown for some species of bacteria and/or phage that the lysogenic state may affect
growth or gross bacterial morphology [75, 76], our initial characterizations comparing theWT
SF370SmR with the CEM1ΔF full phage KO did not detect differences in cell shape, chain length,
colony morphology or growth rates in vitro using enriched media. Further analyses of the compar-
ative growth of these isolates, in conditions that more closely replicate the in vivo environment,
such as human saliva or blood, may yield different results. Moreover, differences may also be seen
between the two strains in chemically defined media varying in metabolic constituents. These
future experiments are supported by our ongoing transcriptional analyses comparing expression
patterns of WT SF370SmR to the full phage KO (CEM1ΔF) and SpyCIM1 (CEM1Δ4) mutants.
These studies indicate that presence of phage and phage-like elements affect many virulence and
metabolic pathways encoded throughout the genome of S. pyogenes (data not shown) and [58].
Virulence and DNase
The phage deletion mutants derived by our methods could be used to analyze the effects that
the individual virulence factor genes encoded by prophage have on the survival of the host bac-
terium. As an example, we chose to compare the ability of wild type SF370SmR and CEM1ΔF
to produce secreted DNases. DNases are thought to facilitate the spread of bacteriophage and
bacteria [61, 77], degrade Neutrophil Extracellular Traps (NETs) [78] [60], and interfere with
toll-like receptor pathways (i.e., TLR9) [79], to allow bacteria to escape and evade the host
immune response [35]. Moreover, many groups have proposed that phage DNases (Sda1/2)
play an important role in the survival and spread of the more pathogenic and contemporary
M1 strains of S. pyogenes [10, 33–37]. As such, an analysis of the secreted DNases of SF370
may elucidate how the bacteriophage encoded DNases affect the virulence of this strain.
SF370 (SF370SmR) encodes three secreted DNases: the chromosomal DNase (sdaB/spd/mf)
and two phage encoded enzymes, spd1 fromF370.1 and spd3 fromF370.3 [2, 61]. We compared
DNase activity between the CEM1ΔF full phage KO, which lacks the spd1 and spd3 genes, and
SF370SmR, which provided an in vitro qualitative assessment of DNase enzymatic activity. The
analysis determined that the wild type SF370 is capable of degrading more DNA in vitro than
CEM1ΔF, presumably due to a lack of phage DNase expression. Whether this effect is the direct
result of a lack of phage encoded DNases and/or more complex interactions between phage, the
chromosomal DNase gene, and bacterial regulators are questions currently being addressed.
However, our preliminary transcriptional analyses have revealed no significant difference in the
expression of the chromosomal encoded DNase (SdaB/Spd/MF) that could be attributed to the
presence of prophage (data not shown). As such, a loss of DNase activity in the mutant seems to
be directly associated with the loss of the two prophage-encoded DNases in CEM1ΔF. Further
analysis of these phage deletion mutants are underway to study the regulation of other phage
encoded virulence factors in both in vitro and in vivo models.
Bacteriophage Lysis and Lysogeny of S. pyogenes
Isogenic phage-cured mutants could also be instrumental in studying numerous mechanisms
of the phage life cycle (e.g., lytic and lysogenic infection), bacterial host defenses to viruses (e.g.,
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Clustered regularly interspaced short palindromic repeat (CRISPR), Abortive infection (Abi)
and Restriction-modification (RM) systems), phage-phage interactions (e.g., helper-viruses or
super-infection exclusion), or other phenotypes associated with lysogenic phages that have
inserted into the CEM1ΔF versus SF370SmR genome.
While SF370SmR contains two CRISPR-Cas loci, which provide resistance to infection
from bacteriophage that have homologous DNA sequences to the CRISPR spacer sequences
[80], we hypothesized that our phage-free mutant strain would be more susceptible to infection
by other bacteriophage (which do not contain CRISPR homologies) since there are no pro-
phage at the potentially shared attB integration sites [13, 32] or other phage-encoded proteins
that might interfere with subsequent infections (e.g., bacteriophage CI-repressors and superin-
fection exclusion genes) [81]. To test this hypothesis, we exposed the mutant strains to super-
natants from cultures of SF370 induced with mitomycin C and found that the phage cured
CEM1ΔFmutant was capable of being re-infected and subsequently lysed by lytic bacterio-
phage. To further identify which phage was responsible for the lytic effect, SF370 phage super-
natants where dropped onto different bacterial lawns of mutants lacking only one the four
phage-elements. While other phage inducing agents may produce different results [82–84],
plaque formation was only seen on the CEM1Δ1 mutant indicator strain, suggesting that
F370.1 potentially was the only viable phage induced with mitomycin C. These results were
supported by similar experiments that used induced supernatants from the four mutants with
triple phage deletions, which each contained only one of the four phage-elements. Plaque for-
mation was only seen in supernatants induced from the CEM1Δ2,3,4 mutant that contained
only F370.1. Finally, we also isolated lysogens from the CEM1ΔF and CEM1Δ1 mutants that
contained F370.1 re-integrated into the original attB site on the chromosome, proving the re-
infection event.
These findings are in agreement with previous genetic analyses and experiments that sug-
gest F370.1 is inducible after mitomycin C treatment [2, 3], while additionally proving that
F370.1 was a fully functional bacteriophage capable of lytic infection and lysogeny. These
results also proved that our phage-cured mutants, derived from our novel counter-selection
method, were capable of being re-infected and/or lysogenized.
Furthermore, when screening CEM1ΔF for lysogeny, we also identified isolates that con-
tained the DNA from SpyCIM1, suggesting that this element may be capable of being trans-
ferred by phage transduction. While the exact mechanism is unknown in S. pyogenes, elements
like SpyCIM1 are often transferred by helper phage in other bacterial genera [8]. Interestingly,
we found that it was much easier to obtain SpyCIM1 deletion mutants from our isolates in
which the F370.1 and/or F370.2 prophage were previously lost from the genome, which sup-
ports a possible helper phage hypothesis.
Taken together, the results and methodology presented here illustrate the utility of these
mutants in analyzing interactions between different streptococcal bacteriophage and/or other
chromosomal elements.
Conclusion
It has long been accepted that lysogenic bacteriophages play an important role in the ability of
particular strains of bacteria to cause disease. However, since most pathogens carry one or
more lysogenic phage, it is difficult to definitively determine the exact contribution of phage to
disease without their precise removal from the genome. This is the first report of a method that
systematically cures S. pyogenes of any and all prophage elements. Our counter–selection tech-
nique has allowed us to precisely manipulate lysogeny in the streptococcal genome. The
derived KO strains are useful tools to directly examine novel bacteriophage interactions in
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S. pyogenes and to elucidate their specific roles in streptococcal survival, pathogenicity, and
evolution. The techniques developed in this study could easily be modified for other bacteria-
bacteriophage systems, and thus could be beneficial to the study of not just streptococcal-
phage interactions but to other areas of research in microbial pathogenesis, ecology or
biotechnology.
Supporting Information
S1 Fig. Construction of the counter-selection vector pFWKR. The diagram outlines the steps
to construct vector pFWKR. At the top is the location of the rpsL gene and upstream promoter
region, with adjacent predicted ORFs and their corresponding Spy numbers, from the genome
sequence of S. pyogenes SF370. The bracketed region of DNA was PCR amplified with primers
described in the S1 Table and digested with MabI (SibEnzyme, Russia) and EcoICRI (Promega,
Madison WI). The amplicon was then ligated into plasmid pFW13, which was previously cut
with MabI and SwaI, to create the counter-selection vector pFWKR. The final vector contains
the kanamycin resistance gene (aacA/aphD) adjacent to the rpsLWT gene, to make up the Janus
cassette. As detailed in the methods section, this counter selection cassette was individually
inserted by homologous recombination into each of the prophage of SF370 to screen for
mutants that had lost a specific virus. Black arrows and blocks indicate the regions PCR ampli-
fied for insertion into the pFW13 vector. The plasmid diagrams indicate relevant restriction
sites, multi-cloning sites (MCSI, MCSII),the Janus Cassette: composed of the kanamycin resis-
tance gene (aacA/aphD) and the wild type streptomycin sensitive 30S ribosomal protein S12
gene (rpsLWT) gene, terminators (term) and the E. coli origin of replication (ori). This figure
was designed with the aid of SnapGene1 software (from GSL Biotech; available at snapgene.
com).
(PDF)
S2 Fig. PFGE analysis of S. pyogenes SF370SmR and 15 permutations of phage deletion
mutants. Pulse field gel electrophoresis (PFGE) patterns of SmaI digested genomic DNA from
which Fig 2. was derived. Lanes encompass digested DNA from the phage wild type strains
SF370 and SF370SmR, as well as all phage KO mutants. Labeled arrows indicate DNA frag-
ments that contain the corresponding integrated phage or phage-like elements, based on the
genome sequence of SF370. A loss or drop of these DNA fragments represents a phage or Spy-
CIM1 deletion. Numbers at top indicate which phages have been deleted (i.e. 1, F370.1
(40.9kb); 2, F370.2 (42.5 kb); 3, F370.3 (33.5Kb); 4, F370.4/SpyCIM1 (13.5kb)). λ, Lambda
ladder, New England Biolabs PFGMarker with DNA fragment size to right of gel. For a better
comparison all phage KO patterns were incorporated into the same figure; lanes corresponding
to phage KOs (1,3) and (2,3), bordered by white boxes, were inserted into this figure from a dif-
ferent PFGE gel run under identical conditions. DNA bands in these lanes were aligned to the
location of the DNA loading wells at the top, as well as to the four bottom DNA bands in all
the lanes, which do not harbor known phage or phage attachment sites.
(PDF)
S3 Fig. Plate view of the DNase activity of WT SF370SmR and the full-phage knockout
mutant CEM1ΔF. Both strains were cultured on DNase Test Agar with Methyl Green for 17
hr. The upper half of the plate contains WT colonies and the lower half of the plate contains
colonies from the full phage knockout mutant CEM1ΔF. The left side of the plate was inocu-
lated from individual colonies grown on Columbia Blood Agar plates and the right side inocu-
lated from overnight cultures grown in BHI medium. Clearing zones around the colonies are a
result of hydrolysis of the DNA and methyl green substrate, signifying DNase activity. This
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figure includes a color and a black and white photograph of the same plate taken at the same
time, to aid in discerning colonies and DNAse activity.
(PDF)
S1 Table. Plasmids and primers used in this study.
(PDF)
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